Edmonds Duncan Registered Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,270
Closed -$257K 116
2024
Q2
$257K Buy
2,270
+400
+21% +$50.6K 0.06% 113
2024
Q1
$259K Sell
1,870
-626
-25% -$78.7K 0.07% 119
2023
Q4
$310K Sell
2,496
-1,500
-38% -$153K 0.08% 97
2023
Q3
$373K Buy
3,996
+900
+29% +$101K 0.1% 88
2023
Q2
$398K Hold
3,096
0.12% 81
2023
Q1
$360K Sell
3,096
-500
-14% -$56K 0.11% 86
2022
Q4
$407K Hold
3,596
0.13% 82
2022
Q3
$290K Hold
3,596
0.1% 90
2022
Q2
$268K Hold
3,596
0.09% 96
2022
Q1
$460K Buy
3,596
+200
+6% +$21.9K 0.13% 80
2021
Q4
$370K Buy
3,396
+596
+21% +$85.6K 0.1% 91
2021
Q3
$383K Buy
2,800
+200
+8% +$25.2K 0.12% 93
2021
Q2
$278K Hold
2,600
0.09% 110
2021
Q1
$234K Buy
2,600
+200
+8% +$18.8K 0.08% 115
2020
Q4
$247K Buy
2,400
+100
+4% +$8.93K 0.08% 108
2020
Q3
$237K Buy
2,300
+100
+5% +$10.4K 0.1% 97
2020
Q2
$223K Buy
+2,200
New +$197K 0.1% 97

Other funds holding DXCM

Edmonds Duncan Registered Investment Advisors's DXCM Position: Q3 2024 in Review

Edmonds Duncan Registered Investment Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,270 shares — an estimated $257K sold.

Edmonds Duncan Registered Investment Advisors first reported a position in DXCM in Q2 2020 and held it in 17 quarters. The position peaked at $460K in Q1 2022. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Edmonds Duncan Registered Investment Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Edmonds Duncan Registered Investment Advisors sold 2,270 DexCom shares in Q3 2024, an estimated $257K.
  • Edmonds Duncan Registered Investment Advisors first reported a position in DexCom in Q2 2020 and held it in 17 quarters.
  • Edmonds Duncan Registered Investment Advisors's DexCom position peaked at $460K in Q1 2022.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.